EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan
TOKYO, April 29, 2026 /PRNewswire/ -- As the global biopharmaceutical industry undergoes rapid restructuring, two powerful forces—policy evolution and supply chain transformation—are reshaping Japan's landscape. On one side, the Ministry of Health,...